Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of safety and immunogenicity of CoronaVac and ChAdOx1 against the SARS-CoV-2 circulating variants of concern (Alpha, Delta, Beta) in Thai healthcare workers.
Angkasekwinai N, Sewatanon J, Niyomnaitham S, Phumiamorn S, Sukapirom K, Sapsutthipas S, Sirijatuphat R, Wittawatmongkol O, Senawong S, Mahasirimongkol S, Trisiriwanich S, Chokephaibulkit K. Angkasekwinai N, et al. Among authors: wittawatmongkol o. Vaccine X. 2022 Mar 5;10:100153. doi: 10.1016/j.jvacx.2022.100153. eCollection 2022 Apr. Vaccine X. 2022. PMID: 35282410 Free PMC article.
Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children.
Chokephaibulkit K, Cressey TR, Capparelli E, Sirisanthana V, Muresan P, Hongsiriwon S, Ngampiyaskul C, Limwongse C, Wittawatmongkol O, Aurpibul L, Kabat B, Toye M, Smith ME, Eksaengsri A, McIntosh K, Yogev R; IMPAACT P1069 Team. Chokephaibulkit K, et al. Among authors: wittawatmongkol o. Antivir Ther. 2011;16(8):1287-95. doi: 10.3851/IMP1931. Antivir Ther. 2011. PMID: 22155910 Free PMC article. Clinical Trial.
Once- versus twice-daily lopinavir/ritonavir tablets in virologically suppressed, HIV-infected, treatment-experienced children: comparative pharmacokinetics and virological outcome after switching to once-daily lopinavir/ritonavir.
Chokephaibulkit K, Nuntarukchaikul M, Phongsamart W, Wittawatmongkol O, Lapphra K, Vanprapar N, Cressey TR. Chokephaibulkit K, et al. Among authors: wittawatmongkol o. J Antimicrob Chemother. 2012 Dec;67(12):2927-31. doi: 10.1093/jac/dks332. Epub 2012 Aug 23. J Antimicrob Chemother. 2012. PMID: 22923483 Clinical Trial.
Pharmacokinetics of darunavir/ritonavir in Asian HIV-1-infected children aged ≥7 years.
Chokephaibulkit K, Prasitsuebsai W, Wittawatmongkol O, Gorowara M, Phongsamart W, Sophonphan J, Kerr SJ, Vanprapar N, Puthanakit T, Pasomsap C, Suwanlerk T, Sekar V, Burger D, Ananworanich J; HIV-NAT 113 Pharmacokinetic Study Group. Chokephaibulkit K, et al. Among authors: wittawatmongkol o. Antivir Ther. 2012;17(7):1263-9. doi: 10.3851/IMP2347. Epub 2012 Sep 6. Antivir Ther. 2012. PMID: 22954687
Immune activation and viral replication after vaccination with an influenza A H1N1 2009 vaccine in HIV-infected children receiving antiretroviral therapy.
Onlamoon N, Unpol P, Boonchan M, Sukapirom K, Wittawatmongkol O, Chokephaibulkit K, Ammaranond P, Pattanapanyasat K. Onlamoon N, et al. Among authors: wittawatmongkol o. Dis Markers. 2013;35(4):221-7. doi: 10.1155/2013/276547. Epub 2013 Sep 5. Dis Markers. 2013. PMID: 24167370 Free PMC article. Clinical Trial.
58 results